Premium
Homegrown mid-market private equity player BanyanTree, which has raised about $300 million across three funds, has participated in a secondary investment, helping one of the promoters curb its shareholding in the company, it is learnt. The PE player, which sold its shareholding in GPT Healthcare Ltd by offloading its stake via ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
